Preclinical Research Market By Service and End User - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 170 Category: Pharma & Healthcare Report Code : HC043102
Preclinical Research Market By Service (In Vivo, In Vitro) End User (Government and academic institutes, Biopharmaceutical companies, Medical device companies) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Preclinical Research Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Preclinical research includes the assessment of potential therapeutic mediations in animals and cells. Candidates for entry into clinical researches would then be able to be chosen dependent on their efficiency and security in disease models. All medications need information from different toxicological preclinical researches to help their potential security in people before clinical preliminaries can start.
Drivers and Restraints
Rising focus of life science organizations on their center abilities combined with ascend in redistributing of noncore capacities is additionally expected to add to the development of preclinical research market. There has been a critical ascent in R&D spending plan for beginning time and late-arrange medicate improvement forms, which is additionally anticipated to add to the market development.
Regional Insights
North America held the biggest share in the worldwide preclinical CRO market and is anticipated to overwhelm the market over the conjecture time frame.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Charles River Laboratories
- Envigo Corporation
- Eurofins Scientific
- PRA Health Sciences, Inc
- Wuxi AppTec
- Medpace, Inc.
- Pharmaceutical Product Development (PPD), LLC
- PARAXEL International Corporation
- ICON Plc.
- Laboratory Corporation of America, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Preclinical Research Market, By Service, Estimates and Forecast, 2017-2027 ($Million)
o In Vitro
o In Vivo
· Preclinical Research Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Biopharmaceutical companies
o Government and academic institutes
o Medical device companies
· Preclinical Research Market, By Key Players
o Charles River Laboratories
o Envigo Corporation
o Eurofins Scientific
o PRA Health Sciences, Inc
o Wuxi AppTec
o Medpace, Inc.
o Pharmaceutical Product Development (PPD), LLC
o PARAXEL International Corporation
o ICON Plc.
o Laboratory Corporation of America, Inc.
· Preclinical Research Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Preclinical Research Market, By Country
o U.S. Preclinical Research Market
o Canada Preclinical Research Market
o Mexico Preclinical Research Market
o Europe
§ Europe Preclinical Research Market, By Country
o Germany Preclinical Research Market
o UK Preclinical Research Market
o France Preclinical Research Market
o Russia Preclinical Research Market
o Italy Preclinical Research Market
o Rest of Europe Preclinical Research Market
o Asia-Pacific
§ Asia-Pacific Preclinical Research Market, By Country
o China Preclinical Research Market
o Japan Preclinical Research Market
o South Korea Preclinical Research Market
o India Preclinical Research Market
o Southeast Asia Preclinical Research Market
o Rest of Asia-Pacific Preclinical Research Market
o South America
§ South America Preclinical Research Market
o Brazil Preclinical Research Market
o Argentina Preclinical Research Market
o Columbia Preclinical Research Market
o Rest of South America Preclinical Research Market
o Middle East and Africa
§ Middle East and Africa Preclinical Research Market
o Saudi Arabia Preclinical Research Market
o UAE Preclinical Research Market
o Egypt Preclinical Research Market
o Nigeria Preclinical Research Market
o South Africa Preclinical Research Market
o Rest of MEA Preclinical Research Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Preclinical Research Market, By Service
5.1. Introduction
5.2. Global Preclinical Research Revenue and Market Share by Service (2017-2027)
5.2.1. Global Preclinical Research Revenue and Revenue Share by Service (2017-2027)
5.3. In Vivo
5.3.1. Global In Vivo Revenue and Growth Rate (2017-2027)
5.4. In Vitro
5.4.1. Global In Vitro Revenue and Growth Rate (2017-2027)
6. Preclinical Research Market, By End User
6.1. Introduction
6.2. Global Preclinical Research Revenue and Market Share by End User (2017-2027)
6.2.1. Global Preclinical Research Revenue and Revenue Share by End User (2017-2027)
6.3. Government and academic institutes
6.3.1. Global Government and academic institutes Revenue and Growth Rate (2017-2027)
6.4. Biopharmaceutical companies
6.4.1. Global Biopharmaceutical companies Revenue and Growth Rate (2017-2027)
6.5. Medical device companies
6.5.1. Global Medical device companies Revenue and Growth Rate (2017-2027)
7. Preclinical Research Market, By Region
7.1. Introduction
7.2. Global Preclinical Research Revenue and Market Share by Regions
7.2.1. Global Preclinical Research Revenue by Regions (2017-2027)
7.3. North America Preclinical Research by Countries
7.3.1. North America Preclinical Research Revenue and Growth Rate (2017-2027)
7.3.2. North America Preclinical Research Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Preclinical Research by Countries
7.4.1. Europe Preclinical Research Revenue and Growth Rate (2017-2027)
7.4.2. Europe Preclinical Research Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Preclinical Research by Countries
7.5.1. Asia-Pacific Preclinical Research Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Preclinical Research Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Preclinical Research by Countries
7.6.1. South America Preclinical Research Revenue and Growth Rate (2017-2027)
7.6.2. South America Preclinical Research Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Preclinical Research by Countries
7.7.1. Middle East and Africa Preclinical Research Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Preclinical Research Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. PRA Health Sciences, Inc
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Eurofins Scientific
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Medpace, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Charles River Laboratories
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Envigo Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Wuxi AppTec
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Pharmaceutical Product Development (PPD), LLC
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. ICON Plc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. PARAXEL International Corporation
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Laboratory Corporation of America, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Global Preclinical Research Market Competition, by Manufacturer
9.1. Global Preclinical Research Financial Overview by Manufacturer (2017-2017)
9.2. Global Preclinical Research Price By Region (2017-2017)
9.3. Top 5 Preclinical Research Manufacturer Market Share
9.4. Market Competition Trend
10. Preclinical Research Market Forecast (2017-2027)
10.1. Global Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Preclinical Research Market Forecast by Regions (2017-2027)
10.2.1. North America Preclinical Research Market Forecast (2017-2027)
10.2.1.1. United States Preclinical Research Market Forecast (2017-2027)
10.2.1.2. Canada Preclinical Research Market Forecast (2017-2027)
10.2.1.3. Mexico Preclinical Research Market Forecast (2017-2027)
10.2.2. Europe Preclinical Research Market Forecast (2017-2027)
10.2.2.1. Germany Preclinical Research Market Forecast (2017-2027)
10.2.2.2. France Preclinical Research Market Forecast (2017-2027)
10.2.2.3. UK Preclinical Research Market Forecast (2017-2027)
10.2.2.4. Russia Preclinical Research Market Forecast (2017-2027)
10.2.2.5. Italy Preclinical Research Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Preclinical Research Market Forecast (2017-2027)
10.2.3. Asia-Pacific Preclinical Research Market Forecast (2017-2027)
10.2.3.1. China Preclinical Research Market Forecast (2017-2027)
10.2.3.2. Japan Preclinical Research Market Forecast (2017-2027)
10.2.3.3. Korea Preclinical Research Market Forecast (2017-2027)
10.2.3.4. India Preclinical Research Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Preclinical Research Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Preclinical Research Market Forecast (2017-2027)
10.2.4. South America Preclinical Research Market Forecast (2017-2027)
10.2.4.1. Brazil Preclinical Research Market Forecast (2017-2027)
10.2.4.2. Argentina Preclinical Research Market Forecast (2017-2027)
10.2.4.3. Columbia Preclinical Research Market Forecast (2017-2027)
10.2.4.4. Rest of South America Preclinical Research Market Forecast (2017-2027)
10.2.5. Middle East and Africa Preclinical Research Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Preclinical Research Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Preclinical Research Market Forecast (2017-2027)
10.2.5.3. Egypt Preclinical Research Market Forecast (2017-2027)
10.2.5.4. Nigeria Preclinical Research Market Forecast (2017-2027)
10.2.5.5. South Africa Preclinical Research Market Forecast (2017-2027)
10.2.5.6. Turkey Preclinical Research Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Preclinical Research Market Forecast (2017-2027)
10.3. Preclinical Research Market Forecast by Service (2017-2027)
10.3.1. Preclinical Research Forecast by Service (2017-2027)
10.3.2. Preclinical Research Market Share Forecast by Service (2017-2027)
10.4. Preclinical Research Market Forecast by End User (2017-2027)
10.4.1. Preclinical Research Forecast by End User (2017-2027)
10.4.2. Preclinical Research Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Preclinical Research Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Preclinical Research Revenue and Revenue Share by Service (2017-2018)
Figure Global In Vivo Revenue and Growth Rate (2017-2018)
Figure Global In Vitro Revenue and Growth Rate (2017-2018)
Table Global Preclinical Research Revenue and Revenue Share by End User (2017-2018)
Figure Global Government and academic institutes Revenue and Growth Rate (2017-2018)
Figure Global Biopharmaceutical companies Revenue and Growth Rate (2017-2018)
Figure Global Medical device companies Revenue and Growth Rate (2017-2018)
Table Global Preclinical Research Revenue by Regions (2017-2018)
Figure North America Preclinical Research Growth Rate (2017-2018)
Figure North America Preclinical Research Revenue and Growth Rate (2017-2018)
Figure North America Preclinical Research by Countries (2017-2018)
Figure North America Preclinical Research Revenue (Million USD) by Countries (2017-2018)
Figure United States Preclinical Research Growth Rate (2017-2018)
Figure United States Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Preclinical Research Growth Rate (2017-2018)
Figure Canada Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Preclinical Research Growth Rate (2017-2018)
Figure Mexico Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Preclinical Research Growth Rate (2017-2018)
Figure Europe Preclinical Research Revenue and Growth Rate (2017-2018)
Figure Europe Preclinical Research by Countries (2017-2018)
Figure Europe Preclinical Research Revenue (Million USD) by Countries (2017-2018)
Figure Germany Preclinical Research Growth Rate (2017-2018)
Figure Germany Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Preclinical Research Growth Rate (2017-2018)
Figure France Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Preclinical Research Growth Rate (2017-2018)
Figure UK Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Preclinical Research Growth Rate (2017-2018)
Figure Russia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Preclinical Research Growth Rate (2017-2018)
Figure Italy Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Preclinical Research Growth Rate (2017-2018)
Figure Rest of Europe Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical Research Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical Research Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Preclinical Research by Countries (2017-2018)
Figure Asia-Pacific Preclinical Research Revenue (Million USD) by Countries (2017-2018)
Figure China Preclinical Research Growth Rate (2017-2018)
Figure China Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Preclinical Research Growth Rate (2017-2018)
Figure Japan Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Preclinical Research Growth Rate (2017-2018)
Figure Korea Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Preclinical Research Growth Rate (2017-2018)
Figure India Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Preclinical Research Growth Rate (2017-2018)
Figure Southeast Asia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preclinical Research Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Preclinical Research Growth Rate (2017-2018)
Figure South America Preclinical Research Revenue and Growth Rate (2017-2018)
Figure South America Preclinical Research by Countries (2017-2018)
Figure South America Preclinical Research Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Preclinical Research Growth Rate (2017-2018)
Figure Brazil Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Preclinical Research Growth Rate (2017-2018)
Figure Argentina Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Preclinical Research Growth Rate (2017-2018)
Figure Columbia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Preclinical Research Growth Rate (2017-2018)
Figure Rest of South America Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical Research Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical Research Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Preclinical Research by Countries (2017-2018)
Figure Middle East and Africa Preclinical Research Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Preclinical Research Growth Rate (2017-2018)
Figure Saudi Arabia Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Preclinical Research Growth Rate (2017-2018)
Figure United Arab Emirates Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Preclinical Research Growth Rate (2017-2018)
Figure Egypt Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Preclinical Research Growth Rate (2017-2018)
Figure Nigeria Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Preclinical Research Growth Rate (2017-2018)
Figure South Africa Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Preclinical Research Growth Rate (2017-2018)
Figure Turkey Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preclinical Research Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preclinical Research Revenue (Millions USD) and Growth Rate (2017-2018)
Table PRA Health Sciences, Inc Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eurofins Scientific Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medpace, Inc. Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Charles River Laboratories Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Envigo Corporation Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Wuxi AppTec Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pharmaceutical Product Development (PPD), LLC Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ICON Plc. Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PARAXEL International Corporation Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Laboratory Corporation of America, Inc. Preclinical Research Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Preclinical Research Market Share by Manufacturer
Figure Global Preclinical Research Revenue and Market Share by Manufacturer
Table Global Preclinical Research Price by Region (2017-2017)
Figure Top 5 Preclinical Research Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Preclinical Research Revenue (Millions USD) and Growth Rate (2018-2025)
Table Preclinical Research Market Forecast by Regions (2018-2025)
Figure North America Preclinical Research Market Forecast (2018-2025)
Figure United States Preclinical Research Market Forecast (2018-2025)
Figure Canada Preclinical Research Market Forecast (2018-2025)
Figure Mexico Preclinical Research Market Forecast (2018-2025)
Figure Europe Preclinical Research Market Forecast (2018-2025)
Figure Germany Preclinical Research Market Forecast (2018-2025)
Figure France Preclinical Research Market Forecast (2018-2025)
Figure UK Preclinical Research Market Forecast (2018-2025)
Figure Russia Preclinical Research Market Forecast (2018-2025)
Figure Italy Preclinical Research Market Forecast (2018-2025)
Figure Rest of Europe Preclinical Research Market Forecast (2018-2025)
Figure Asia-Pacific Preclinical Research Market Forecast (2018-2025)
Figure China Preclinical Research Market Forecast (2018-2025)
Figure Japan Preclinical Research Market Forecast (2018-2025)
Figure Korea Preclinical Research Market Forecast (2018-2025)
Figure India Preclinical Research Market Forecast (2018-2025)
Figure Southeast Asia Preclinical Research Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Preclinical Research Market Forecast (2018-2025)
Figure South America Preclinical Research Market Forecast (2018-2025)
Figure Brazil Preclinical Research Market Forecast (2018-2025)
Figure Argentina Preclinical Research Market Forecast (2018-2025)
Figure Columbia Preclinical Research Market Forecast (2018-2025)
Figure Rest of South America Preclinical Research Market Forecast (2018-2025)
Figure Middle East and Africa Preclinical Research Market Forecast (2018-2025)
Figure Saudi Arabia Preclinical Research Market Forecast (2018-2025)
Figure United Arab Emirates Preclinical Research Market Forecast (2018-2025)
Figure Egypt Preclinical Research Market Forecast (2018-2025)
Figure Nigeria Preclinical Research Market Forecast (2018-2025)
Figure South Africa Preclinical Research Market Forecast (2018-2025)
Figure Turkey Preclinical Research Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Preclinical Research Market Forecast (2018-2025)
Figure Global Preclinical Research Forecast by Service (2018-2025)
Figure Global Preclinical Research Market Share Forecast by Service (2018-2025)
Figure Global Preclinical Research Forecast by Service (2018-2025)
Figure Global Preclinical Research Forecast by End User (2018-2025)
Figure Global Preclinical Research Market Share Forecast by End User (2018-2025)
Figure Global Preclinical Research Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|